Dorzolamide Hydrochloride Solution
Product Images NDC 72266-197

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride (NDC 72266-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Dorzolamide Carton Label (Dorzolamide HCl Carton)

Dorzolamide Carton Label (Dorzolamide HCl Carton)
Carton label for Dorzolamide Hydrochloride Ophthalmic Solution USP 2%, distributed by Fosun Pharma USA Inc. The label indicates a 10 mL sterile solution for topical application in the eye. It includes storage instructions, inactive ingredients, preservative details, and directions to see the package insert for dosage. The product is made in India and features a barcode.*
FDA Label Image

Dorzolamide Label (Dorzolamide HCl Label)

Dorzolamide Label (Dorzolamide HCl Label)
Label for Dorzolamide Hydrochloride 2% ophthalmic solution, 10 mL, from Fosun Pharma USA Inc. The label states the solution contains 22.3 mg of dorzolamide hydrochloride per mL (equivalent to 20 mg dorzolamide). It is for topical application in the eye, prescription use only. Storage instructions are to keep between 15°C and 30°C and protect from light. The label includes a barcode and distributor information indicating it is made in India.*
FDA Label Image

Figure-a (Figure A)

Figure-a (Figure A)
A labeled line drawing of a small pharmaceutical bottle illustrating its components: the cap, a tamper-evident ring, and the bottle body. The image is a black-and-white schematic typical for instructional or packaging-related diagrams.*
FDA Label Image

Figure-b (Figure B)

Figure-b (Figure B)
An instructional illustration showing one hand holding a bottle with a dropper cap and the other hand lifting or twisting the cap, likely demonstrating how to open or prepare the ophthalmic solution bottle.*
FDA Label Image

Figure-c (Figure C)

Figure-c (Figure C)
An instructional illustration showing the removal or attachment of a child-resistant safety cap from a small bottle, likely for Dorzolamide Hydrochloride ophthalmic solution. The diagram includes an arrow indicating the direction to turn the cap to open or close the bottle.*
FDA Label Image

Figure-d (Figure D)

Figure-d (Figure D)
An instructional line drawing labeled Figure-D showing a hand administering an ophthalmic solution by placing a drop into the eye. The illustration depicts a finger positioned near the lower eyelid, pulling it down to create a pocket for the drop.*
FDA Label Image

Figure-e (Figure E)

Figure-e (Figure E)
An instructional illustration showing a hand administering ophthalmic solution into the eye. The first part depicts a person holding a dropper bottle above an eye, with a finger pulling down the lower eyelid. The second part is a close-up showing a drop of solution falling onto the eye, demonstrating proper eye drop application technique.*
FDA Label Image

Figure-f (Figure F)

Figure-f (Figure F)
An instructional line drawing showing a person holding an ophthalmic solution bottle and twisting the cap open. The image demonstrates how to open the bottle for Dorzolamide Hydrochloride ophthalmic solution 20 mg/mL by Fosun Pharma USA Inc.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Dorzolamide Hydrochloride, showing its molecular arrangement including the sulfonamide group, amine, and hydrochloride components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.